1 |
29263590 |
10.14202/vetworld.2017.1307-1313 |
2022 |
Immunocytochemical study of canine lymphomas and its correlation with exposure to tobacco smoke. |
PAX5 |
2 |
29296913 |
10.1182/bloodadvances.2017009472 |
2022 |
Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL. |
PAX5 |
3 |
33398683 |
10.1007/s12105-020-01276-3 |
2022 |
Combined Modality Management of Sinonasal Anaplastic Lymphoma Kinase Negative Anaplastic Large Cell Lymphoma in a Geriatric Patient-Report of a Rare Case. |
PAX5 |
4 |
34049715 |
10.1016/j.pathol.2021.02.013 |
2022 |
Expression of BCL6 in paediatric B-cell acute lymphoblastic leukaemia and association with prognosis. |
PAX5 |
5 |
34190415 |
10.1002/dc.24821 |
2022 |
ALK-negative anaplastic large cell lymphoma, null type with aberrant expression of PAX5 and CD138: A diagnostic pitfall. |
PAX5 |
6 |
34282671 |
10.1177/03009858211030523 |
2022 |
Histopathological features and immunophenotyping of canine transmural gastrointestinal lymphoma using full-thickness biopsy samples. |
PAX5 |
7 |
34310368 |
10.1097/PAS.0000000000001785 |
2022 |
Reactive Intralymphovascular Immunoblastic Proliferations Mimicking Aggressive Lymphomas. |
PAX5 |
8 |
34371436 |
10.1016/j.leukres.2021.106683 |
2022 |
Proposal and clinical application of molecular genetic risk scoring system, MRplus, for BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia- report from a single centre. |
PAX5 |
9 |
34374890 |
10.1007/s12029-021-00662-6 |
2022 |
Primary ALK-Positive Large B Cell Lymphoma of Pancreas. |
PAX5 |
10 |
34499743 |
10.1111/1556-4029.14879 |
2022 |
Sudden death in an adolescent due to undiagnosed classic Hodgkin lymphoma. |
PAX5 |
11 |
34547766 |
10.1182/bloodadvances.2021004895 |
2022 |
Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia. |
PAX5 |
12 |
34560683 |
10.1097/PAS.0000000000001813 |
2022 |
A Comprehensive Clinicopathologic and Molecular Study of 19 Primary Effusion Lymphomas in HIV-infected Patients. |
PAX5 |
13 |
34591292 |
10.1007/s12185-021-03229-0 |
2022 |
Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation. |
PAX5 |
14 |
34657128 |
10.1038/s41375-021-01448-2 |
2022 |
Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study. |
PAX5 |
15 |
34707037 |
10.3960/jslrt.21025 |
2022 |
t(9;14)(p13;q32)/PAX5-IGH translocation as a secondary cytogenetic abnormality in diffuse large B-cell lymphoma. |
PAX5 |
16 |
34747234 |
10.1177/00031348211054526 |
2022 |
Primary Parotid Non-Hodgkin's B-Cell Lymphoma in an Elderly Woman on Pembrolizumab for Metastatic Invasive Papillary Urothelial Cell Carcinoma of the Bladder. |
PAX5 |
17 |
34753926 |
10.1038/s41408-021-00570-9 |
2022 |
Cancer drivers and clonal dynamics in acute lymphoblastic leukaemia subtypes. |
PAX5 |
18 |
34787376 |
10.1002/cnr2.1587 |
2022 |
Philadelphia-like acute lymphoblastic leukemia: Characterization in a pediatric cohort in a referral center in Colombia. |
PAX5 |
19 |
34801601 |
10.1016/j.humpath.2021.11.007 |
2022 |
Clinicopathological features of syncytial variant nodular sclerosis Hodgkin lymphoma. |
PAX5 |
20 |
34872475 |
10.2174/1566524021666211206094046 |
2022 |
PAX5 Haploinsufficiency Induces Low T Cell Infiltration in the Cancer Microenvironment via Reduced Chemokines. |
PAX5 |
21 |
34896889 |
10.1016/j.anndiagpath.2021.151868 |
2022 |
Merkel cell carcinoma in the setting of hematologic disease is associated with unique features and potential pitfalls. |
PAX5 |
22 |
34907175 |
10.1038/s41467-021-27197-5 |
2022 |
Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemia. |
PAX5 |
23 |
34910327 |
10.1111/jop.13269 |
2022 |
Oral versus extra-oral plasmablastic lymphoma: A comparative analysis of 101 cases. |
PAX5 |
24 |
34924212 |
10.1016/j.pathol.2021.09.019 |
2022 |
Monocytoid switch in an adult with B-cell precursor acute lymphoblastic leukaemia characterised by the PAX5 P80R mutation. |
PAX5 |
25 |
34933343 |
10.1182/bloodadvances.2021005634 |
2022 |
Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001. |
PAX5 |
26 |
34940123 |
10.3390/cimb43030149 |
2022 |
Molecular Genetics of Pre-B Acute Lymphoblastic Leukemia Sister Cell Lines during Disease Progression. |
PAX5 |
27 |
34957727 |
10.2478/raon-2021-0050 |
2022 |
Clinical impacts of copy number variations in B-cell differentiation and cell cycle control genes in pediatric B-cell acute lymphoblastic leukemia: a single centre experience. |
PAX5 |
28 |
34981542 |
10.1111/cup.14196 |
2022 |
Immunohistochemistry of the oncofetal protein IMP3 is helpful in the diagnosis of intravascular large B-cell lymphoma using skin biopsy. |
PAX5 |
29 |
35004601 |
10.3389/fpubh.2021.805757 |
2022 |
Risk Factors for Childhood Leukemia: Radiation and Beyond. |
PAX5 |
30 |
35011638 |
10.3390/cells11010076 |
2022 |
Pax-5 Protein Expression Is Regulated by Transcriptional 3'UTR Editing. |
PAX5 |
31 |
35013921 |
10.1007/s12029-021-00790-z |
2022 |
Spindle Variant Primary Diffuse Large B Cell Lymphoma of the Colon: Case Report and Literature Review. |
PAX5 |
32 |
35067515 |
10.1097/PAS.0000000000001828 |
2022 |
Composite Classic Hodgkin Lymphoma and Follicular Lymphoma: A Clinicopathologic Study of 22 Cases With Review of 27 Additional Cases in the Literature. |
PAX5 |
33 |
35091549 |
10.1038/s41408-022-00616-6 |
2022 |
Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter? |
PAX5 |
34 |
35131871 |
10.1158/0008-5472.CAN-21-3386 |
2022 |
Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice. |
PAX5 |
35 |
35179642 |
10.1007/s00277-021-04394-2 |
2022 |
CD20/CD79a/PAX5/CD3-negative post-transplant lymphoma with aberrant actin and desmin co-expression-a potential differential diagnostic pitfall between PTLD and PTSMT. |
PAX5 |
36 |
35192684 |
10.1182/blood.2022015444 |
2022 |
Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia. |
PAX5 |
37 |
35205758 |
10.3390/cancers14041010 |
2022 |
Low Mutational Burden of Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren's Syndrome. |
PAX5 |
38 |
35226982 |
10.31083/j.fbl2702039 |
2022 |
Cytofluorimetric assay to investigate variability in blinatumomab <i>in vitro</i> response. |
PAX5 |
39 |
35231988 |
10.3760/cma.j.issn.0253-2727.2022.01.005 |
2022 |
[Mutational spectrum and its prognostic significance in childhood acute lymphoblastic leukemia based on next-generation sequencing technology]. |
PAX5 |
40 |
35245931 |
10.1182/bloodadvances.2021006328 |
2022 |
Characterization of PAX5 intragenic tandem multiplication in pediatric B-lymphoblastic leukemia by optical genome mapping. |
PAX5 |
41 |
35264043 |
10.1177/10406387221078608 |
2022 |
Pax5 and CD3 immunophenotyping of lymphoma in 2 central bearded dragons. |
PAX5 |
42 |
35264486 |
10.11405/nisshoshi.119.227 |
2022 |
[Endoscopic mucosal resection of localized plasmablastic lymphoma with early rectal cancer:a rare case report and literature review]. |
PAX5 |
43 |
35286176 |
10.1080/15513815.2022.2050325 |
2022 |
A Curious Case of Morphologically Deceptive Pediatric B-Lymphoblastic Leukemia with Granular Blebbed Blasts and DLBCL-Like Biopsy Findings. |
PAX5 |
44 |
35307403 |
10.1016/j.humpath.2022.03.005 |
2022 |
CD3-and CD20-negative extramedullary non-Hodgkin leukemia/lymphoma: a histopathological study of 118 cases. |
PAX5 |
45 |
35322462 |
10.1111/his.14652 |
2022 |
Epstein-Barr virus infection patterns in nodular lymphocyte-predominant Hodgkin lymphoma. |
PAX5 |
46 |
35395675 |
10.1093/carcin/bgac034 |
2022 |
Genomic profile of radiation-induced early-onset mouse B-cell lymphoma recapitulates features of Philadelphia chromosome-like acute lymphoblastic leukemia in humans. |
PAX5 |
47 |
35409379 |
10.3390/ijms23074021 |
2022 |
Hypermethylation-Mediated Silencing of <i>CIDEA</i>, <i>MAL</i> and <i>PCDH17</i> Tumour Suppressor Genes in Canine DLBCL: From Multi-Omics Analyses to Mechanistic Studies. |
PAX5 |
48 |
35442117 |
10.1177/10406387221090281 |
2022 |
Primary nervous system lymphoma in cats. |
PAX5 |
49 |
35448666 |
10.3390/vetsci9040168 |
2022 |
Bcl-2 Immunoexpression in Feline Epitheliotropic Intestinal T-Cell Lymphomas. |
PAX5 |
50 |
35460405 |
10.1093/ajcp/aqac044 |
2022 |
IRF8 as a Novel Marker to Differentiate Between CD30-Positive Large Cell Lymphomas. |
PAX5 |
51 |
35467057 |
10.1111/cas.15380 |
2022 |
PAX5 alterations in an infant case of KMT2A-rearranged leukemia with lineage switch. |
PAX5 |
52 |
35512254 |
10.1093/ajcp/aqab179 |
2022 |
The Effectiveness of Dual-Staining Immunohistochemistry in the Detection of Mantle Cell Lymphoma in the Bone Marrow. |
PAX5 |
53 |
35521914 |
10.1177/10668969221099627 |
2022 |
ALK-positive Large B-Cell Lymphoma Presenting as a Circumscribed Breast Mass with Germinal Center Immunophenotype. |
PAX5 |
54 |
35523507 |
10.1136/bcr-2021-247430 |
2022 |
Epstein-Barr virus-positive mucocutaneous ulcer, plasmablastic type, associated with nodal CD4+ angioimmunoblastic T-cell lymphoma and generalised pruritus: a self-limiting lymphoproliferative disorder resembling cutaneous plasmablastic lymphoma. |
PAX5 |
55 |
35562413 |
10.1038/s41379-022-01091-x |
2022 |
Human herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristics. |
PAX5 |
56 |
35562965 |
10.3390/ijms23094574 |
2022 |
Multi-Cohort Transcriptomic Subtyping of B-Cell Acute Lymphoblastic Leukemia. |
PAX5 |
57 |
35575765 |
10.1097/PAS.0000000000001917 |
2022 |
Nodular Lymphocyte-predominant Hodgkin Lymphoma With Nodular Sclerosis: An Underrecognized Feature Associated With Pattern D. |
PAX5 |
58 |
35600178 |
10.1016/j.amsu.2022.103786 |
2022 |
Immunohistochemical expression of transcription factors PAX5, OCT2, BCL6 and transcription regulator P53 in Non-Hodgkin lymphomas: A diagnostic cross-sectional study. |
PAX5 |
59 |
35646671 |
10.3389/fonc.2022.883141 |
2022 |
Case Report: Intravascular Large B-Cell Lymphoma: A Clinicopathologic Study of Four Cases With Review of Additional 331 Cases in the Literature. |
PAX5 |
60 |
35664405 |
10.7759/cureus.24592 |
2022 |
Primary Endometrial Diffuse Large B-cell Lymphoma: A Rare Disease and Diagnostic Challenge in an Asymptomatic Postmenopausal Woman. |
PAX5 |
61 |
35673721 |
10.3760/cma.j.cn112151-20211117-00836 |
2022 |
[ALK-positive large B-cell lymphoma with EBV infection or cyclin D1 expression: a clinicopathological analysis of 3 cases]. |
PAX5 |
62 |
35774514 |
10.3389/fgene.2022.827840 |
2022 |
A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma. |
PAX5 |
63 |
35789115 |
10.1111/his.14718 |
2022 |
Hodgkinoid histiocytosis: an atypical nodal CD30 and S100-positive histiocytosis with eosinophilia. |
PAX5 |
64 |
35864305 |
10.1038/s41698-022-00295-3 |
2022 |
Peripheral blood DNA methylation profiles predict future development of B-cell Non-Hodgkin Lymphoma. |
PAX5 |
65 |
35911381 |
10.3389/fmed.2022.896647 |
2022 |
Thymic Extranodal Marginal-Zone Lymphoma of Mucosa-Associated Lymphoid Tissue: Pathological Features, <sup>18</sup>F-FDG PET/CT Findings and Prognosis in 12 Cases. |
PAX5 |
66 |
35920299 |
10.1096/fj.202200061RR |
2022 |
Mcm2 hypomorph leads to acute leukemia or hematopoietic stem cell failure, dependent on genetic context. |
PAX5 |
67 |
35926290 |
10.1016/j.anndiagpath.2022.151974 |
2022 |
The utility of PAX8 in comparison with PAX5 immunohistochemical staining in the diagnosis of Hodgkin lymphoma. |
PAX5 |
68 |
35949809 |
|
2022 |
Transient atypical lymphoplasmacytic proliferation of the endometrium associated with pyometra: a case report. |
PAX5 |
69 |
35977101 |
10.1182/blood.2022016056 |
2022 |
Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma. |
PAX5 |
70 |
35979119 |
10.12998/wjcc.v10.i17.5708 |
2022 |
Gray zone lymphoma effectively treated with cyclophosphamide, doxorubicin, vincristine, prednisolone, and rituximab chemotherapy: A case report. |
PAX5 |
71 |
35987347 |
10.1016/j.humpath.2022.07.024 |
2022 |
EBV-positive nodular lymphocyte predominant Hodgkin lymphoma: a single institution experience. |
PAX5 |
72 |
36032657 |
10.3389/pore.2022.1610482 |
2022 |
The Prognostic Value of Eight Immunohistochemical Markers Expressed in the Tumor Microenvironment and on Hodgkin Reed-Sternberg Cells in Pediatric Patients With Classical Hodgkin Lymphoma. |
PAX5 |
73 |
36077495 |
10.3390/ijms231710095 |
2022 |
The Pleiotropy of <i>PAX5</i> Gene Products and Function. |
PAX5 |
74 |
31935288 |
10.1182/bloodadvances.2019000947 |
2021 |
Expression of the prosurvival kinase HCK requires PAX5 and mutated MYD88 signaling in MYD88-driven B-cell lymphomas. |
PAX5 |
75 |
32161948 |
10.1093/gigascience/giaa016 |
2021 |
An image dataset related to automated macrophage detection in immunostained lymphoma tissue samples. |
PAX5 |
76 |
32202217 |
10.1177/0300985820906889 |
2021 |
Equine Intestinal Lymphoma: Clinical-Pathological Features, Immunophenotype, and Survival. |
PAX5 |
77 |
32202225 |
10.1177/0300985820913265 |
2021 |
Spectrum of Posttransplant Lymphoproliferations in NSG Mice and Their Association With EBV Infection After Engraftment of Pediatric Solid Tumors. |
PAX5 |
78 |
32235787 |
10.3390/ijms21062193 |
2021 |
The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic Leukemia. |
PAX5 |
79 |
32245383 |
10.1186/s12920-020-0709-y |
2021 |
Comprehensive chromosomal aberrations in a case of a patient with TCF3-HLF-positive BCP-ALL. |
PAX5 |
80 |
32368831 |
10.1002/gcc.22858 |
2021 |
Impact of immunophenotypic characteristics on genetic subgrouping in childhood acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) study L04-16. |
PAX5 |
81 |
32420699 |
10.1002/cam4.3136 |
2021 |
Serine-227 in the N-terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma. |
PAX5 |
82 |
32590454 |
10.1097/PAI.0000000000000863 |
2021 |
Aberrant Cytoplasmic Terminal Deoxynucleotidyl Transferase (TdT) Immunostaining on Previously Frozen, Formalin-fixed Paraffin-embedded Tissue: Cryotomy-induced Antigen Diffusion (CIAD). |
PAX5 |
83 |
32592278 |
10.1002/gcc.22882 |
2021 |
Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol. |
PAX5 |
84 |
32622430 |
10.1016/j.acthis.2020.151548 |
2021 |
Identification of aspartame-induced haematopoietic and lymphoid tumours in rats after lifetime treatment. |
PAX5 |
85 |
32646889 |
10.3324/haematol.2020.250423 |
2021 |
DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch. |
PAX5 |
86 |
32684618 |
10.12659/AJCR.921840 |
2021 |
Primary Isolated Lymphoplasmacytic Lymphoma (LPL) of the Stomach: A Case Report. |
PAX5 |
87 |
32693409 |
10.1182/blood.2020006164 |
2021 |
Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia. |
PAX5 |
88 |
32731299 |
10.1111/bjh.17002 |
2021 |
High-risk B-cell acute lymphoblastic leukaemia presenting with hypereosinophilia and acquiring a novel PAX5 fusion on relapse. |
PAX5 |
89 |
32769356 |
10.4103/IJPM.IJPM_343_18 |
2021 |
High-grade transformation in nodular lymphocyte predominant Hodgkin lymphoma. |
PAX5 |
90 |
32911536 |
10.1182/blood.2019004381 |
2021 |
An intact gut microbiome protects genetically predisposed mice against leukemia. |
PAX5 |
91 |
32991677 |
10.5858/arpa.2020-0135-OA |
2021 |
CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center. |
PAX5 |
92 |
33004416 |
10.1101/gad.340216.120 |
2021 |
EBF1 and Pax5 safeguard leukemic transformation by limiting IL-7 signaling, Myc expression, and folate metabolism. |
PAX5 |
93 |
33036026 |
10.1182/blood.2020005756 |
2021 |
Germline PAX5 mutation predisposes to familial B-cell precursor acute lymphoblastic leukemia. |
PAX5 |
94 |
33038982 |
10.1016/j.beha.2020.101193 |
2021 |
Molecular markers in ALL: Clinical implications. |
PAX5 |
95 |
33079423 |
10.1111/pin.13038 |
2021 |
Mantle cell lymphoma with EBV-positive Hodgkin and Reed-Sternberg-like cells in a patient after autologous PBSCT: Phenotypically distinct but genetically related tumors. |
PAX5 |
96 |
33094664 |
10.1080/15476286.2020.1838783 |
2021 |
LncRNAs in adaptive immunity: role in physiological and pathological conditions. |
PAX5 |
97 |
33154497 |
10.1038/s41598-020-76206-y |
2021 |
Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis. |
PAX5 |
98 |
33206936 |
10.1182/blood.2020005650 |
2021 |
Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia. |
PAX5 |
99 |
33357483 |
10.1016/S2352-3026(20)30353-7 |
2021 |
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study. |
PAX5 |
100 |
33369444 |
10.31557/APJCP.2020.21.12.3493 |
2021 |
Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis. |
PAX5 |